Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Aug;56(2):157–158. doi: 10.1038/bjc.1987.176

Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.

G Kenter 1, J M Bonfrer 1, A P Heintz 1
PMCID: PMC2002153  PMID: 3663467

Full text

PDF
157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bleker O. P., Ketting B. W., van Wayjen-Eecen B., Kloosterman G. J. The significance of microscopic involvement of the parametrium and/or pelvic lymph nodes in cervical cancer stages IB and IIA. Gynecol Oncol. 1983 Aug;16(1):56–62. doi: 10.1016/0090-8258(83)90009-4. [DOI] [PubMed] [Google Scholar]
  2. Burghardt E., Holzer E. Diagnosis and treatment of microinvasive carcinoma of the cervix uteri. Obstet Gynecol. 1977 Jun;49(6):641–653. [PubMed] [Google Scholar]
  3. Kato H., Morioka H., Aramaki S., Tamai K., Torigoe T. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix. Am J Obstet Gynecol. 1983 Feb 1;145(3):350–354. doi: 10.1016/0002-9378(83)90723-8. [DOI] [PubMed] [Google Scholar]
  4. Kato H., Morioka H., Tsutsui H., Aramaki S., Torigoe T. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer. Cancer. 1982 Oct 1;50(7):1294–1296. doi: 10.1002/1097-0142(19821001)50:7<1294::aid-cncr2820500712>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  5. Kato H., Tamai K., Morioka H., Nagai M., Nagaya T., Torigoe T. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma. Cancer. 1984 Oct 15;54(8):1544–1546. doi: 10.1002/1097-0142(19841015)54:8<1544::aid-cncr2820540813>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  6. Kato H., Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 1977 Oct;40(4):1621–1628. doi: 10.1002/1097-0142(197710)40:4<1621::aid-cncr2820400435>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  7. Maruo T., Shibata K., Kimura A., Hoshina M., Mochizuki M. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization. Cancer. 1985 Jul 15;56(2):302–308. doi: 10.1002/1097-0142(19850715)56:2<302::aid-cncr2820560217>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  8. Suehiro Y., Kato H., Nagai M., Torigoe T. Flow cytometric analysis of tumor antigen TA-4 in cervical cytologic specimens. Cancer. 1986 Apr 1;57(7):1380–1384. doi: 10.1002/1097-0142(19860401)57:7<1380::aid-cncr2820570723>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  9. Ueda G., Inoue Y., Yamasaki M., Inoue M., Tanaka Y., Hiramatsu K., Saito J., Nishino T., Abe Y. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors. Int J Gynecol Pathol. 1984;3(3):291–298. doi: 10.1097/00004347-198403000-00005. [DOI] [PubMed] [Google Scholar]
  10. Van Nagell J. R., Jr, Roddick J. W., Jr, Lowin D. M. The staging of cervical cancer: inevitable discrepancies between clinical staging and pathologic findinges. Am J Obstet Gynecol. 1971 Aug 1;110(7):973–978. doi: 10.1016/0002-9378(71)90551-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES